Article Fingerprint
ReserarchID
PDDTM479RL
In search for specific early ultrasound signs that could indicate an increased risk of hereditary or acquired disorders of the fetus, scientific research confirms the value of exceptional ultrasound findings nuchal translucency (NT). The aim of the study was to determine the predictive value of the diameter of fetal NT in the detection chromosomopathy. The investigation included 317 pregnant women with monofetal pregnancies gestational age of 11 to 14 weeks. The control group consisted of pregnant women in whom amniocentesis was recognized after a neat result of fetal karyotype. We determined the limit of physiological and pathological findings of the value of NT, but we used the diameter of NT that we get in pregnant women with pathological score of amniocentesis as a potentially pathological values. Mean value of NT in the control group was 1.92 ± 0.39 mm, and the group with pathological findings karyotype fetus was 2.49 ± 0.37 mm, which is a statistically significant difference (p 0.05).The probability that a patient with negative findings to be healthy is NT 1.0. NT sensitivity as a marker for chromosomopathy was 1.0. The rate of false positive findings of the 0.026. Specificity of NT as a marker for chromosomopathy is 0.97. The probability that a patient with positive findings NT really be sick is 0.5. Valid findings NT can be considered safe ultrasonographic markers in the assessment of absence chromosomopathy. Pathological finding, given the low positive predictive value of NT must be amended and other prenatal tests before pregnant invasive give advice on prenatal diagnosis.
Dr. Dragan Loncar. 1970. \u201cPredictive value of fetal nuchal translucency in the screening of chromosomal aberrations\u201d. Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology & Medicine N/A (GJMR Volume 11 Issue B4): .
Crossref Journal DOI 10.17406/gjmra
Print ISSN 0975-5888
e-ISSN 2249-4618
Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.
Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.
Total Score: 106
Country: Serbia
Subject: Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology & Medicine
Authors: Dr. Dragan Loncar (PhD/Dr. count: 1)
View Count (all-time): 121
Total Views (Real + Logic): 20589
Total Downloads (simulated): 10982
Publish Date: 1970 01, Thu
Monthly Totals (Real + Logic):
This paper attempted to assess the attitudes of students in
Advances in technology have created the potential for a new
Inclusion has become a priority on the global educational agenda,
In search for specific early ultrasound signs that could indicate an increased risk of hereditary or acquired disorders of the fetus, scientific research confirms the value of exceptional ultrasound findings nuchal translucency (NT). The aim of the study was to determine the predictive value of the diameter of fetal NT in the detection chromosomopathy. The investigation included 317 pregnant women with monofetal pregnancies gestational age of 11 to 14 weeks. The control group consisted of pregnant women in whom amniocentesis was recognized after a neat result of fetal karyotype. We determined the limit of physiological and pathological findings of the value of NT, but we used the diameter of NT that we get in pregnant women with pathological score of amniocentesis as a potentially pathological values. Mean value of NT in the control group was 1.92 ± 0.39 mm, and the group with pathological findings karyotype fetus was 2.49 ± 0.37 mm, which is a statistically significant difference (p 0.05).The probability that a patient with negative findings to be healthy is NT 1.0. NT sensitivity as a marker for chromosomopathy was 1.0. The rate of false positive findings of the 0.026. Specificity of NT as a marker for chromosomopathy is 0.97. The probability that a patient with positive findings NT really be sick is 0.5. Valid findings NT can be considered safe ultrasonographic markers in the assessment of absence chromosomopathy. Pathological finding, given the low positive predictive value of NT must be amended and other prenatal tests before pregnant invasive give advice on prenatal diagnosis.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.